Funnel plot for MACE incidence to rule out publication bias.

<p>Funnel plot was generated using a fixed-effect model by Review Manager 5.2.0.</p

Clinical events in follow-up.

<p>Spontaneous MI = spontaneous myocardial infarction; ACS = acute coronary syndrome;</p><p>TVR = target vessel revascularization; MACE = major adverse cardiovascular events;</p><p>NA = not available.</p><p>Clinical events in follow-up.</p

Quality of included RCTs.

<p>NA = not available.</p><p>Quality of included RCTs.</p

Funnel plot for PMI incidence to rule out publication bias.

<p>Funnel plot was generated using a fixed-effect model by Review Manager 5.2.0.</p

Characteristics of included studies.

<p>PCI = percutaneous coronary intervention; CK-MB = creatine kinase-MB; UNL = upper normal limit of normal; NSTE-ACS = non-ST-segment elevation acute coronary syndrome; ROMA trial = Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of periprocedural myocardial necrosis; ROMA II trial = Comparison of high reloading Rosuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of periprocedural myocardial necrosis; NA = not available.</p><p>Characteristics of included studies.</p

Funnel plot for PMI incidence for patients with prior low-dose statin use.

<p>Forest plot was generated using Review Manager 5.2.0 for patients with prior low-dose statin use from individual and pooled trials. The incidence of PMI was expressed as a dichotomous variable, and the results were expressed as odds ratios (OR) with 95% confidence intervals (CI). Heterogeneity across trials was evaluated with I² statistic, defined as I²>50%. A random-effect model was used for the subgroup with prior low-dose statin treatment because heterogeneity existed for this group.</p

Forest plots for PMI incidence for patients stratified by different clinical presentation.

<p>Forest plots were generated using Review Manager 5.2.0 for patients with stable angina, ACS or mixed disease presentation from individual and pooled trials. The incidence of PMI was expressed as a dichotomous variable, and the results were expressed as odds ratios (OR) with 95% confidence intervals (CI). Heterogeneity across trials was evaluated with I² statistic, defined as I²>50%. Because the heterogeneity was low, a fixed-effect model was used.</p

Funnel plot for PMI incidence for statin naïve patients.

<p>Forest plot was generated using Review Manager 5.2.0 for statin naïve patients from individual and pooled trials. The incidence of PMI was expressed as a dichotomous variable, and the results were expressed as odds ratios (OR) with 95% confidence intervals (CI). Heterogeneity across trials was evaluated with I² statistic, defined as I²>50%. Because the heterogeneity was low, a fixed-effect model was used.</p

Additional file 10 of Transcriptome analysis reveals the roles of phytohormone signaling in tea plant (Camellia sinensis L.) flower development

Additional file 10: Table S7: Two-way ANOVA test F-value of genes expression levels related to cytokinin biosynthesis and signaling transduction for three C. sinensis cultivars (BY1, HJY and SCZ) affected by development stage (S) and cultivar (C)

Characteristics of included studies.

<p>PCI = percutaneous coronary intervention; CK-MB = creatine kinase-MB; UNL = upper normal limit of normal; NSTE-ACS = non-ST-segment elevation acute coronary syndrome;</p><p>Characteristics of included studies.</p